Table 3.
The efficacy of AZM, BDQ, and WX-081 against Mycobacterium Abscess infection in zebrafish in vivo.
| Groups | concentration (μg/mL) |
Whole-body fluorescence intensity (pixel, mean ± SE) |
Head fluorescence intensity (pixel, mean ± SE) |
|---|---|---|---|
| Control group (n = 10) |
– | 361707 ± 7139** | 55473 ± 2670** |
| Model group (n = 10) |
– | 671089 ± 22305 | 132412 ± 9989 |
| AZM (n = 10) |
62.5 | 433684 ± 11910**a3 | 78397 ± 4815** |
| BDQ (n = 10) |
15.6 | 438648 ± 8280**a1 | 79664 ± 5809** |
| WX-081 (n = 10) |
1.95 | 535952 ± 23902**a1 | 101579 ± 6065a3 |
| 3.91 | 520519 ± 18208**a1 | 101495 ± 10160a2 | |
| 7.81 | 492988 ± 17182**a1 | 93190 ± 5468a2 | |
| 15.6 | 462296 ± 14360**a1 | 89877 ± 10333* | |
| 31.2 | 419947 ± 13302**a2 | 76778 ± 4906** | |
| 62.5 | 375347 ± 11359** | 70976 ± 5726** |
Compared with the model control group, *p < 0.05, **p < 0.01.
Compared with 62.5 μg/mL WX-081, a1p < 0.001, a2p < 0.05, a3p < 0.01.